Key result
Epinephrine aggravates bupivacaine-induced cardiac toxicity by increasing calcium overload, oxygen consumption, and reactive oxygen species production, worsening cardiac contractile dysfunction.
Why the study?
Does epinephrine worsen cardiac toxicity in experimental models and patients with bupivacaine overdose?
Does epinephrine worsen cardiac toxicity in experimental models and patients with bupivacaine overdose?
Epinephrine may worsen bupivacaine-induced cardiac toxicity by aggravating calcium overload and increasing reactive oxygen species production.
Answers are grounded in this paper and cite their sources.
May caution against epinephrine in bupivacaine toxicity; leaves open confirmation in prospective clinical trials.
Overdose bupivacaine disturbs both electrophysiologic and hemodynamic function by blocking Na channels, affecting Ca transient and reuptake, inhibiting mitochondria respiration and lipid metabolism. Adrenergic activation aggravates Ca overload, increases oxygen consumption, increases ROS production, and therefore worsens cardiac contractile dysfunction.
No takes yet. Share an insight, caveat, or question.
A 2017 study conducted a review in Bupivacaine-induced cardiac toxicity. Epinephrine was evaluated. Epinephrine aggravates bupivacaine-induced cardiac toxicity by increasing calcium overload, oxygen consumption, and reactive oxygen species production, worsening cardiac contractile dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: